Protein kinase C isozymes as potential targets for anticancer therapy.
about
A unified approach to the important protein kinase inhibitor balanol and a proposed analoguePHLiPPing the switch on Akt and protein kinase C signalingC1 Domain-targeted isophthalate derivatives induce cell elongation and cell cycle arrest in HeLa cellsEffect of staurosporine on the mobility and invasiveness of lung adenocarcinoma A549 cells: an in vitro studyA rapid method for characterization of protein relatedness using feature vectors.Binding of curcumin and its long chain derivatives to the activator binding domain of novel protein kinase C.Neuronal ELAV proteins enhance mRNA stability by a PKCalpha-dependent pathwayProtein kinase C isoforms zeta and iota mediate collagenase expression and cartilage destruction via STAT3- and ERK-dependent c-fos inductionPKC activation by resveratrol derivatives with unsaturated aliphatic chainDown-regulation of protein kinase Cδ inhibits inducible nitric oxide synthase expression through IRF1Neurotensin phosphorylates GSK-3alpha/beta through the activation of PKC in human colon cancer cellsControl of protein kinase C activity, phorbol ester-induced cytoskeletal remodeling, and cell survival signals by the scaffolding protein SSeCKS/GRAVIN/AKAP12.Corneal angiogenic privilege: angiogenic and antiangiogenic factors in corneal avascularity, vasculogenesis, and wound healing (an American Ophthalmological Society thesis)Relevant molecular markers and targets.The tetramethoxyflavone zapotin selectively activates protein kinase C epsilon, leading to its down-modulation accompanied by Bcl-2, c-Jun and c-Fos decrease.Down-regulation of PKCζ in renal cell carcinoma and its clinicopathological implications.PKC in Regenerative Therapy: New Insights for Old Targets.Protein kinase Calpha and epsilon small-molecule targeted therapeutics: a new roadmap to two Holy Grails in drug discovery?Berberine enhances inhibition of glioma tumor cell migration and invasiveness mediated by arsenic trioxide.Bryostatin-1: pharmacology and therapeutic potential as a CNS drug.Protein kinase C controls vesicular transport and secretion of apolipoprotein E from primary human macrophages.Conformationally constrained analogues of diacylglycerol. 30. An investigation of diacylglycerol-lactones containing heteroaryl groups reveals compounds with high selectivity for Ras guanyl nucleotide-releasing proteinsProtein Kinase C α Modulates Estrogen-Receptor-Dependent Transcription and Proliferation in Endometrial Cancer Cells.Centrosomal PKCbetaII and pericentrin are critical for human prostate cancer growth and angiogenesis.Characterization of the differential roles of the twin C1a and C1b domains of protein kinase C-deltaReactive oxygen species regulate urokinase plasminogen activator expression and cell invasion via mitogen-activated protein kinase pathways after treatment with hepatocyte growth factor in stomach cancer cells.Amphiregulin-EGFR signaling regulates PTHrP gene expression in breast cancer cells.Sustained PKCβII activity confers oncogenic properties in a phospholipase D- and mTOR-dependent manner.Hyaluronan-CD44 interaction with protein kinase C(epsilon) promotes oncogenic signaling by the stem cell marker Nanog and the Production of microRNA-21, leading to down-regulation of the tumor suppressor protein PDCD4, anti-apoptosis, and chemotheraAltered phosphorylation of cytoskeleton proteins in sickle red blood cells: the role of protein kinase C, Rac GTPases, and reactive oxygen species.Targeting TRPC6 channels in oesophageal carcinoma growth.Drug-subphenotype interactions for cancer in type 2 diabetes mellitus.Apoptotic Effects of Rotundic Acid on Human Esophagus and Lung Cancer Cells.Signaling coupled epigenomic regulation of gene expression.Development of diacyltetrol lipids as activators for the C1 domain of protein kinase C.Kinase gene expression and subcellular protein expression pattern of protein kinase C isoforms in curcumin-treated human hepatocellular carcinoma Hep 3B cells.Essential role of TRPC6 channels in G2/M phase transition and development of human glioma.Activation of protein kinase C{eta} by type I interferonsEpidermal growth factor-dependent cyclooxygenase-2 induction in gliomas requires protein kinase C-delta.Enzastaurin inhibits tumours sensitive and resistant to anti-EGFR drugs.
P2860
Q24616153-39778140-D1B6-43F3-9C6B-B26A1EC85B23Q24625894-48F882D2-4B48-4841-B213-812B3C6709C5Q28478227-8157DE59-431D-4238-9828-FDFEEEFD4F1FQ33462048-30E41135-8BBA-4729-BEFB-8C54BF3595CAQ33539776-903B0256-EDFF-4B5C-A785-8D3676CDE01CQ33744860-B25D008A-1A97-4EA6-B421-F6F053B3EBDDQ33922898-6906E7AA-49A9-4681-B429-40B6CC54B67DQ33991241-BD6F9B68-EF8B-4DF8-BD82-AFF917FFB528Q34534789-DDFA5A85-722C-4553-BB7C-879B48864A16Q34551021-4EC6FD4A-58A5-451C-B1E0-4D8CDE0DC6BEQ35060343-2676BE74-CE5E-4779-BA1A-5DD0D482048EQ35515316-5469185A-4A00-4F4B-BFA1-5015FEDE546FQ35662667-CA5B18C2-E6A0-4C48-897D-35CC04C2CD7FQ35791117-C892E0A5-6591-4E16-B635-B84E0AA5541AQ35866974-2F5A058D-B76E-4FBB-8625-83B6AED816BAQ36034954-6846408E-422B-4225-B6B5-5D74F8194E9DQ36376317-2B75DC11-2A2F-4D8C-8F6A-446D29496DD5Q36381266-3153AD1E-5977-432D-A1ED-801697867041Q36509566-9975921A-8159-4712-B7B0-365220FDD3BBQ36533472-055ACEC8-1D1F-48EC-B7E0-8EF809E69B2FQ36620898-623465A4-AE85-4361-96FB-AE5E4DAE5A46Q36952426-7AEF50C3-BEA2-416C-B51E-FC5A047080B6Q36988609-29EF7D9F-BA0D-44D7-B467-CA7AE31135ABQ37003631-834E202F-8576-4F87-B6EB-BDC47D67655AQ37036491-245FE89B-7B12-4452-AFCE-A2EAE59AF143Q37233640-85F506CF-F931-44A1-8712-551157F58CFFQ37315788-93CD7AE0-50CC-4B73-B385-27CF6AC82AACQ37405255-348C3E9A-649F-4417-AAF6-0316D97D1BCBQ37446718-20CD1377-1708-4044-BBDC-A877B629E535Q37709708-0B578482-6957-497A-AE40-2DF4E85A0F07Q37710561-51B68635-6480-4162-BA23-03EC571FE506Q38388443-A4C6BECC-3BBD-4408-A704-A5530E7C8047Q38774903-644F9084-1451-4A07-8151-30057EFD0D1EQ39398333-5A036AE3-671B-4FDC-83BD-8B3C04BB0D22Q39402279-62494B61-066E-4787-B89F-C650111485D3Q39545389-27E67673-0A86-44F2-B3EF-FF6E84F533F1Q39691899-DC630CB0-0341-472C-A2BE-490AB87BAA18Q39884881-0F9BB773-59DD-4DF8-97ED-42F7C32E9FDEQ39890940-3B490562-3290-437F-829D-FD7FD1CA8935Q39956127-6AF4CCF4-3C11-4B7A-91A9-8C08F741D571
P2860
Protein kinase C isozymes as potential targets for anticancer therapy.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Protein kinase C isozymes as potential targets for anticancer therapy.
@ast
Protein kinase C isozymes as potential targets for anticancer therapy.
@en
type
label
Protein kinase C isozymes as potential targets for anticancer therapy.
@ast
Protein kinase C isozymes as potential targets for anticancer therapy.
@en
prefLabel
Protein kinase C isozymes as potential targets for anticancer therapy.
@ast
Protein kinase C isozymes as potential targets for anticancer therapy.
@en
P356
P1476
Protein kinase C isozymes as potential targets for anticancer therapy.
@en
P2093
Johann Hofmann
P304
P356
10.2174/1568009043481579
P577
2004-03-01T00:00:00Z